MENU
SLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
SELLAS Life Sciences Group (SLS) Earnings Date & Reports
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
SLS is expected to report earnings to rise 10.00% to -5 cents per share on November 18
Q3'26
Est.
$-0.05
Q2'26
Est.
$-0.05
Q1'26
Beat
by $0.02
Q4'25
Beat
by $0.02
Q3'25
Beat
by $0.02
The last earnings report on August 11 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 9.29M shares outstanding, the current market capitalization sits at 3.12B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
13
Web
https://www.sellaslifesciences.com